reports
EXOSENS AND THEON INTERNATIONAL FRAME THEIR LONG-TERM COMMERCIAL RELAT...
EXOSENS AND THEON INTERNATIONAL FRAME THEIR LONG-TERM COMMERCIAL RELATIONSHIP TO COVER NIGHT VISION DEVICES BUSINESS EXOSENS AND THEON INTERNATIONAL FRAME THEIR LONG-TERM COMMERCIAL RELATIONSHIP TO COVER NIGHT VISION DEVICES BUSINESS PRESS RELEASEMÉRIGNAC, FRANCE– SEPTEMBER, 10th 2024 Exosens and Theon have signed a multi-year image intensifier tubes delivery agreement for 2025/2026 with an option for 2027 including volumes commitment, covering Theon needs and enabling Exosens to smooth out its operations in an increasing market demand. Exosens, a high-tech company focused on providing m...
- Roland Pfaender
- MBA
- CFA
- CCRA
- Steven Gould
- Roland Pfaender
- MBA
- CFA
- CCRA
- Steven Gould
- Aurelien Sivignon
- Yan Derocles
Exosens : Solid H1 results confirm trajectory expected for 2024
>Marked adjusted gross margin improvement in H1 for both divisions - Exosens this morning posted good-quality H1 results, in line with the trajectory expected for 2024. The targets from the IPO were confirmed. On already-reported H1 revenues of € 187m, up 50% y-o-y (+35% org.), the adjusted gross margin came in at 48.8%, or an improvement of 3.5 pts y-o-y, driven by both divisions: 47.1% on Amplification (+250bp) and 51.1% for the D&I segment (+430bp). Adjusted EBIT...
- Aurelien Sivignon
- Yan Derocles
Exosens : Solides résultats S1 qui confirment la trajectoire attendue ...
>Progression marquée au S1 de la marge brute ajustée dans les deux divisions - Exosens publie ce matin des résultats S1 de bonne facture, en ligne avec la trajectoire attendue pour 2024. Les objectifs de l’IPO sont confirmés. Pour un CA S1 déjà publié de 187 M€ en hausse de 50% y-o-y (+35% org), la marge brute ajustée atteint 48.8% du CA soit une progression de 3.5 pts y-o-y tirée par les deux divisions : 47.1% sur l’Amplification (+250bp) et 51.1% sur le segment D&...
Exosens - H1 2024 Results
Exosens - H1 2024 Results H1 2024 RESULTS PRESS RELEASEMÉRIGNAC, FRANCE – 3 SEPTEMBER 2024 H1 2024 RESULTS STRONG GROWTH AND PROFITABILITY, FULLY ON TRACK TO DELIVER FY2024 GUIDANCE Strong revenue growth of +50% to €186.9 million, driven by organic growth (+35% on a like for like basis) and successful integration of strategic acquisitionsAdjusted gross margin of €91.1m in H1 2024, 48.8% of revenue (+350bps vs. H1 2023)Significant increase of the profitability, with the adjusted EBITDA reaching €56.1m in H1 2024 (vs. €34.0m in H1 2023), or 30.0% of revenue (vs 27.2% in H1 2023)Strong d...
EXOSENS - RESULTATS - S1 2024
EXOSENS - RESULTATS - S1 2024 RESULTATS – S1 2024 COMMUNIQUÉ DE PRESSEMÉRIGNAC, FRANCE - 3 SEPTEMBRE 2024 PREMIER SEMESTRE 2024 FORTES CROISSANCE ET RENTABILITÉ, PARFAITEMENT EN LIGNE AVEC LES OBJECTIFS 2024 Forte croissance du chiffre d'affaires de 50 % à 186,9 millions d'euros, tiré par la croissance organique (+35 % à périmètre constant) et par des intégrations d’acquisitions stratégiques réussiesMarge brute ajustée de 91,1 millions d’euros au S1 2024, soit 48,8 % du chiffre d’affaires (soit une augmentation de 350 points de base par rapport au S1 2023)Augmentation significative de...
EXOSENS COMPLETES THE ACQUISITION OF LR TECH, LEADER IN SPECTRORADIOME...
EXOSENS COMPLETES THE ACQUISITION OF LR TECH, LEADER IN SPECTRORADIOMETER BASED SOLUTIONS EXOSENS COMPLETES THE ACQUISITION OF LR TECH, LEADER IN SPECTRORADIOMETER BASED SOLUTIONS PRESS RELEASEMÉRIGNAC, FRANCE AND QUEBEC, CANADA – SEPTEMBER, 2nd 2024 Exosens announces the completion of the acquisition of Quebec-based LR Tech, a specialist in FTIR (Fourier Transform Infra-Red) spectroradiometers.This acquisition will enable Exosens to complete its instruments offering for high-end detectors and imagers, targeting science and environmental markets for major players. It will further streng...
EXOSENS FINALISE L'ACQUISITION DE LR TECH, LEADER DES SOLUTIONS DE SPE...
EXOSENS FINALISE L'ACQUISITION DE LR TECH, LEADER DES SOLUTIONS DE SPECTRORADIOMÉTRIE EXOSENS FINALISE L'ACQUISITION DE LR TECH, LEADER DES SOLUTIONS DE SPECTRORADIOMÉTRIE COMMUNIQUÉ DE PRESSEMÉRIGNAC, FRANCE ET QUÉBEC, CANADA - 2 SEPTEMBRE 2024 Exosens annonce la finalisation de l'acquisition de la société québécoise LR Tech, spécialiste des spectroradiomètres infrarouge à transformée de Fourier (Fourier Transform Infra-Red, FTIR).Cette acquisition permettra à Exosens de compléter son offre de systèmes de détection et d’imagerie haut de gamme à destination des acteurs leader des marchés ...
EXOSENS COMPLETES THE CLOSING OF THE ACQUISITION OF CENTRONIC, LEADER ...
EXOSENS COMPLETES THE CLOSING OF THE ACQUISITION OF CENTRONIC, LEADER IN RADIATION DETECTION SOLUTIONS EXOSENS COMPLETES THE CLOSING OF THE ACQUISITION OF CENTRONIC, LEADER IN RADIATION DETECTION SOLUTIONS PRESS RELEASEMÉRIGNAC, FRANCE AND CROYDON, UNITED KINGDOM – AUGUST, 1st 2024 Exosens announces the closing of the acquisition of UK-based Centronic, a specialist in radiation detectors and devices. This strategic merger will enable the combined group to provide high-end detectors for nuclear market, to Business-to-Business customers, leveraging advanced technological capabilities.T...
- Fehmi Ben Naamane
ODDO BHF Small & MIDCAP MORNING NEWS - 24/07/2024
The Platform Group (TPG) is a software company that is active across 20 industries through its digital platform solutions. Via its four segments (consumer goods, freight goods, industrial goods, service and retail goods), it serves both B2B and B2C customers. Given the growing revenues (2023-2026e CAGR +14.7%) and adjusted EBITDA margins (+270bp to 7.8% in 2026e vs 2023), as well as a solid financial profile (equity ratio >30%, average positive FCF of c.€ 8m for 2024e to 2026e) and un...
OSE OSE IMMUNOTHERAPEUTICS SA
VAC PIERRE & VACANCES SA
FLY SOCIETE FONCIERE LYONNAISE SA
POM PLASTIC OMNIUM SE
MMB LAGARDERE SCA
ITP INTERPARFUMS
CDA COMPAGNIE DES ALPES SA
NEX NEXANS SA
TIETO TIETOEVRY OYJ
MMT METROPOLE TELEVISION SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
COFA COFACE SA
LFDE LA FRANCAISE DE L'ENERGIE SA
NHH NH HOTEL GROUP SA
IBG IBERPAPEL GESTION S.A.
COPN COSMO PHARMACEUTICALS NV
FTG111 FLATEXDEGIRO AG
MVC METROVACESA SA
SAB BANCO DE SABADELL SA
NSI NSI N.V.
AEDAS AEDAS HOMES SA
EXN EXCLUSIVE NETWORKS SA
HGEA HGEARS AG
EXENS EXOSENS
- Fehmi Ben Naamane
ODDO BHF Small & MIDCAP MORNING NEWS - 07/24/2024
The Platform Group (TPG) is a software company that is active across 20 industries through its digital platform solutions. Via its four segments (consumer goods, freight goods, industrial goods, service and retail goods), it serves both B2B and B2C customers. Given the growing revenues (2023-2026e CAGR +14.7%) and adjusted EBITDA margins (+270bp to 7.8% in 2026e vs 2023), as well as a solid financial profile (equity ratio >30%, average positive FCF of c.€ 8m for 2024e to 2026e) and un...
OSE OSE IMMUNOTHERAPEUTICS SA
VAC PIERRE & VACANCES SA
FLY SOCIETE FONCIERE LYONNAISE SA
POM PLASTIC OMNIUM SE
MMB LAGARDERE SCA
ITP INTERPARFUMS
CDA COMPAGNIE DES ALPES SA
NEX NEXANS SA
TIETO TIETOEVRY OYJ
MMT METROPOLE TELEVISION SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
COFA COFACE SA
LFDE LA FRANCAISE DE L'ENERGIE SA
NHH NH HOTEL GROUP SA
IBG IBERPAPEL GESTION S.A.
COPN COSMO PHARMACEUTICALS NV
FTG111 FLATEXDEGIRO AG
MVC METROVACESA SA
SAB BANCO DE SABADELL SA
NSI NSI N.V.
AEDAS AEDAS HOMES SA
EXN EXCLUSIVE NETWORKS SA
HGEA HGEARS AG
EXENS EXOSENS
- Aurelien Sivignon
- Yan Derocles
Exosens : Buoyant H1 sales which confirm the strong growth trajectory ...
>H1 up +50% y-o-y (+35% org.) - Exosens published this morning buoyant H1 sales, up 50% y-o-y to € 187m (in line). Organic growth totalled 35%, adjusted for the three acquisitions made in 2023 (Telops, El-Mul, ProxiVision), benefiting from a significant increase in volumes (in our opinion especially in Amplification) and a persistently positive price effect. In contrast to the Q1 revenue communicated as part of the IPO, we have calculated a level of organic growth co...
- Aurelien Sivignon
- Yan Derocles
Exosens : CA S1 dynamique qui confirme la trajectoire de forte croissa...
>S1 en progression de 50% y-o-y (+35% org.) - Exosens publie ce matin un CA S1 de très bonne facture en progression de 50% y-o-y à 187 M€ (en ligne). La croissance organique s’établit à 35%, retraitée des 3 acquisitions réalisées en 2023 (Telops, El-Mul, ProxiVision), bénéficiant d’une progression significative des volumes (selon nous surtout dans l’Amplification) et d’un effet prix qui reste positif. Par différence avec le CA T1 communiqué dans le cadre de l’IPO, no...
STRONG FIRST HALF 2024 REVENUE WITH CONTINUING GROWTH MOMENTUM
STRONG FIRST HALF 2024 REVENUE WITH CONTINUING GROWTH MOMENTUM H1 2024 REVENUE PRESS RELEASEMÉRIGNAC, FRANCE – 24 JULY, 2024 STRONG FIRST HALF 2024 REVENUE WITH CONTINUING GROWTH MOMENTUM Consolidated revenue of €186.9 million for the first half 2024, representing a growth of 49.5% compared to H1 2023.Revenues driven by organic growth (+35.0% on a like-for-like basis) and successful integration of strategic acquisitions.2024 revenue guidance confirmed. Exosens (Euronext FR001400Q9V2 – EXENS), a high-tech company focused on providing mission and performance-critical amplification, de...
PREMIER SEMESTRE 2024: UN CHIFFRE D’AFFAIRES ÉLEVÉ ET UNE DYNAMIQUE DE...
PREMIER SEMESTRE 2024: UN CHIFFRE D’AFFAIRES ÉLEVÉ ET UNE DYNAMIQUE DE CROISSANCE CONTINUE CHIFFRE D’AFFAIRES – S1 2024 COMMUNIQUÉ DE PRESSEMÉRIGNAC, FRANCE – LE 24 JUILLET 2024 PREMIER SEMESTRE 2024UN CHIFFRE D’AFFAIRES ÉLEVÉ ET UNE DYNAMIQUE DE CROISSANCE CONTINUE Chiffre d'affaires consolidé de 186,9 millions d'euros au premier semestre 2024, soit une croissance de 49,5 % par rapport au S1 2023.Chiffre d'affaires tiré par la croissance organique (+35,0 % à périmètre constant) et par des intégrations d’acquisitions stratégiques réussies.Confirmation de la guidance de chiffre d’affa...
- Aurelien Sivignon
- Yan Derocles
Exosens : Leadership sur des marchés de niche exposés au supercycle de...
Fabricant de composants électro-optiques à haute valeur ajoutée, notamment de tubes intensificateurs de lumière pour jumelles de vision nocturne, Exosens est exposé favorablement au supercycle de la défense, alors qu’il bénéficie en même temps de perspectives de croissance soutenue sur ses marchés de niche dans le civil. Le business model d’Exosens nous semble attractif et nous apprécions particulièrement son exposition à la défense (2/3 du CA), son leadership technologique, indu...
- Aurelien Sivignon
- Yan Derocles
Exosens : Leadership in niche markets with exposure to the defence sup...
As a manufacturer of high value-added electro-optical components, including image intensifier tubes for night vision goggles, Exosens enjoys favourable exposure to the defence supercycle, while benefiting from sustainable growth prospects in its niche civil markets. We find Exosens’s business model attractive, particularly its exposure to defence (2/3 of sales), its technological, industrial and commercial leadership, and its superior profitability (adjusted EBIT margin 24.5%). W...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.